Latest DTU publications
-
ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
Journal article
Sammons EL. et al, (2024), Ophthalmology
-
Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus.
Journal article
Chew Sue Mei S. et al, (2024), Endocrinology, diabetes & metabolism case reports, 2024, 23 - 133
-
Live to eat and eat to live longer.
Journal article
Adler A. and Saksena R., (2023), Nat Food
-
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Journal article
Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669
-
Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
Journal article
Bethel MA. et al, (2023), Cardiovasc Diabetol, 22
-
Teplizumab approval for type 1 diabetes in the USA.
Journal article
Beran D. et al, (2023), Lancet Diabetes Endocrinol, 11, 78 - 80
-
Joint longitudinal and time-to-event modeling compared with standard Cox modeling in patients with type 2 diabetes with and without established cardiovascular disease: an analysis of the EXSCEL trial.
Journal article
Oulhaj A. et al, (2023), Diabetes Obes Metab
-
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward
Journal article
Kc S. et al, (2023), International Journal of Health Policy and Management, 12
-
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply.
Journal article
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 841 - 842
-
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.
Journal article
Butterly E. et al, (2022), BMJ Open, 12
-
Endpoints and estimands: understanding trials of weight-loss drugs.
Journal article
Adler AI., (2022), Nat Med, 28, 2005 - 2006
-
How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?
Journal article
Cowie MR. et al, (2022), International journal of cardiology, 365, 61 - 68
-
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
Journal article
Xu S. et al, (2022), Cardiovasc Diabetol, 21
-
Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study.
Journal article
Bidulka P. et al, (2022), Diabetes, obesity & metabolism
-
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Journal article
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 645 - 654
-
NICE guidelines on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma.
Journal article
Adler AI. et al, (2022), Lancet Respir Med
-
Glucocorticoid-induced hyperglycaemia and diabetes: Call for action.
Journal article
Golubic R. et al, (2022), Diabet Med, 39
-
Insulin resistance and incident heart failure: a meta-analysis.
Journal article
Erqou S. et al, (2022), European journal of heart failure
-
The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized trials
Conference paper
Preiss D. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186
-
Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials.
Journal article
Preiss D. et al, (2022), Diabetes Care, 45, e1 - e2
CONTACT US
Phone: +44 (0)1865 857240
Email: dtu@dtu.ox.ac.uk